The Open Philanthropy Project spoke with Dr. Shineman of the Alzheimer’s
Drug Discovery Foundation (ADDF) as part of its investigation into
Alzheimer’s disease. Conversation topics included the ADDF’s research
priorities, challenges and opportunities in the Alzheimer’s disease
funding space, and the importance of biomarker development, as well as a
number of other issues facing the field.